NICOLE MERENSZTEIN: Open Payments
NPI 1558916163 · PASSAIC, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,683 in 74 payments from 14 companies in 2025. Trend: 2023 $1,110 · 2024 $1,744 · 2025 $1,683
Food & beverage: $1,683
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $419 |
| Merck Sharp & Dohme LLC | 13 | $321 |
| Amgen Inc. | 7 | $216 |
| Abbott Laboratories | 3 | $159 |
| PFIZER INC. | 15 | $137 |
| Novartis Pharmaceuticals Corporation | 7 | $131 |
| BridgeBio Pharma, Inc. | 3 | $58 |
| Lilly USA, LLC | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| SCPHARMACEUTICALS INC. | 2 | $48 |
Products named: VERQUVO, CAMZYOS, REPATHA, ELIQUIS, CARDIOMEMS, LEQVIO, Attruby, VYNDAQEL.
Industry payments across NJ — which companies pay providers there.
